Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the effect of saffron and duloxetine on pain and depression in rheumatoid arthritis
IRCT20171106037265N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in rheumatoid arthritis (RA), major depressive disorder (MDD) and pain comparing Saffron with Duloxetine (2 arms). Primary endpoints: Pain reduction and Depression improvement. Started Dec 2017; status: completed.
02
Drugs
saffronduloxetine
03
Conditions
rheumatoid arthritis (RA)major depressive disorder (MDD)pain
Beyond the preview
Go deeper on IRCT20171106037265N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171106037265N1.